Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹175.05
Market cap: ₹215.0 Cr
Revenue (annual): ₹68.67 Cr
Net profit (annual): ₹6.79 Cr
P/E (TTM): 20.4×Sector 47.4×
Promoter holding: 31.56%+0.30% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Other Announcement 3 Financial Results 3 Earnings Call 3 Board Meeting Date 3 Promoter Buying 2 Fund Raise 2 Results Update 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 15:33 IST BSE

Debt & Borrowing

Sanjivani Paranteral Debt & Borrowing

Sanjivani Paranteral Limited (BSE: 531569) issued an initial disclosure for FY 2026-27 confirming it is not identified as a 'Large Corporate' under SEBI norms. The company reported zero outstanding borrowings as of March 31, 2026.

Read the filing ↗